documented in trauma,4 it has not to our knowledge been studied in obstetrics. Multiplate uses 3 mL of hirudin-anticoagulated whole blood sampled in special vacutainer tubes; analysis time is 6 min and it is easy to use at the bedside and can be set to the patient's actual temperature. It is recommended that the freshly sampled blood stabilize at room temperature before analysis, but in severe bleeding, analysis can be started immediately. Therefore, it can be advantageous compared to laboratory platelet counts. The theoretical principles and background of multiple electrode aggregometry have been previously explained. 4 We present a case of PPH in which Multiplate was used to guide intraoperative platelet transfusion and evaluate postoperative haemostasis.
A 39-year-old G2P1 woman at 36 + 6 weeks of gestation was admitted for induction of labour due to fetal macrosomia. The patient was healthy and pregnancy had been otherwise uneventful. Induction of labour with misoprostol 0.05 mg started at 15.00 h and by 20.00 h there were regular uterine contractions. At 22.30 h, after a membrane sweep, painless vaginal bleeding with blood clots occurred which stopped spontaneously. Membrane rupture occurred at 01.00 h the next morning and at 03.00 h, following further vaginal bleeding, an oxytocin infusion was started. Laboratory results showed a normal haemoglobin (Hb), internationalized ratio (INR) and platelet count (Table 1) . At approximately 06.40 h the contractions became stronger and were accompanied by significant vaginal bleeding and pathological fetal heart rate decelerations. Oxytocin was discontinued at which point blood loss was 1. Thromboprophylaxis with low-molecular-weight heparin was started on day 3 and continued until day 9. The Multiplate data (area under curve) showed that there was profound dysfunction of the ADP receptor, the arachidonic acid pathway (metabolism to thromboxane A2 and/or the TXA2 receptor ASPI) and the vWF interaction (RISTO), whereas collagen and thrombin-induced activation (COL and TRAP, respectively) were only moderately decreased (Fig. 1 ). This pattern with initially low Multiplate ADP-receptor function, but no disturbance of COL/TRAP has been shown in trauma patients. 4 Multiplate results were checked against an alternative point-of-care platelet function monitor, VerifyNOW (Accumetrics, San Diego, CA, USA) which indicated normal reactivity (261 PRU). However, Vasodilator Stimulated Phosphoprotein (VASP) analysis for the ADP-P2Y12 receptor showed only 35% reactivity, corroborating our Multiplate results (the patient was not receiving platelet function altering medications). This differs from the platelet count, which remained stable after day 4 when it was >60 · 109/L. A limitation in the interpretation of these data is that the measured platelet function is correlated to the platelet count when using the Multiplate system, an effect that might be especially pronounced when the platelet concentration falls to low levels.
During the immediate postoperative period, platelet reactivity for all agonists increased;
hyper-reactivity was seen in the collagen and thrombin pathways whereas the other pathways experienced a moderate increase in reactivity (still below reference intervals).
Platelet reactivity increased above the reference intervals for all pathways except ADP on postoperative day 8. As high platelet counts increase the Multiplate signals, there may be an increased risk for thromboembolism.6 However, it is unknown whether this applies to all complex deliveries. ROTEM parameters (both EXTEM and FIBTEM-MCFs) were still within reference intervals at this point, and plasma-fibrinogen levels did not show an acute phase reactant increase. In this case, our transfusion experience reflects recommendations in the trauma literature to use an increased ratio of FFP and platelets to red blood cells and the opinion that obstetric haemorrhage can be similarly managed.7 UK guidelines for transfusion recommend a 1:1:1 transfusion ratio (RBC:FFP:platelets) in the critical care setting.8 Supporting evidence is weaker in the obstetric setting than in trauma since there is less tissue damage and medical intervention is usually closer to hand.8 In the immediate postoperative period we adopted a conservative approach to platelet transfusion so the platelet count did not increase above 50 · 109/L and Multiplate ADP/ASPI/RISTO were still low. There was no clinical evidence of ongoing bleeding, although Hb decreased to
